Sep 27, 2022
Pfizer has submitted a request for the Food and Drug Administration to authorize a 10-microgram booster dose of its bivalent COVID-19 vaccine booster for emergency use in children aged 5-11.
Sep 26, 2022
Health care providers who treat uninsured or underinsured patients with commercially procured bebtelovimab, a COVID-19 monoclonal antibody therapy for outpatients at high risk for hospitalization, may be eligible for free replacement doses from the Department of Health and Human Services. HHS plans…
Sep 26, 2022
Moderna Friday submitted its request that the Food and Drug Administration authorize for emergency use its bivalent COVID-19 vaccine for children and adolescents between the ages of 12 and 17 years old. The bivalent version of its mRNA vaccine is designed to target both the original strain of SARS-…
Sep 19, 2022
AHA will co-host a Sept. 27 Facebook Live event with AdventHealth on the importance of getting children vaccinated and boosted against COVID-19, which will also cover the new bivalent booster shots.
Sep 12, 2022
Insured and uninsured Americans can receive the new bivalent Pfizer or Moderna COVID-19 booster and other COVID-19 vaccines at no cost as long as the federal government continues to purchase and distribute them, the Centers for Medicare…
Sep 8, 2022
The Biden Administration will make over 170 million doses of the bivalent COVID-19 vaccine booster available to Americans for free at pharmacies, doctor’s offices, health centers, and state and local health departments, the White House announced today.
Sep 8, 2022
As kids head back to school, Children’s Mercy is sharing helpful information for parents and teens on COVID-19 vaccines, urging that everyone age six months and older get vaccinated. The info emphasizes the facts about COVID-19 vaccines, including how they were developed, how mRNA vaccines works…
Sep 6, 2022
The CDC recommended Pfizer’s updated COVID-19 vaccine booster for Americans aged 12 and older and Moderna’s updated COVID-19 vaccine booster for Americans aged 18 and older, as recommended by its vaccine advisory committee.
Sep 1, 2022
The Food and Drug Administration yesterday announced it has amended the emergency use authorizations for Pfizer’s and Moderna’s COVID-19 vaccines to account for new, bivalent formulations designed to install immunity against the SARS-CoV-2 omicron variant.